Monthly Archives: February 2026

AI Threatens to Reveal What HIPAA Promised to Protect

Medical information shared with chatbots lacks protection. Health data given to AI chatbots from companies outside the healthcare industry does not receive HIPAA privacy protections that apply to doctors and hospitals.

A New York University research team found that AI can be used to restore a patient’s identifying data, and thus circumvent HIPAA. Threats to the privacy of medical data have long existed. Data leaks and hacker invasions have exposed personal, sometimes embarrassing health care data. As AI becomes increasingly integrated into the health care industry, many people wonder whether AI-powered chatbots and automated receptionists used by doctors truly protect patients’ private medical data.

HIPAA applied to medical data gathered by providers, organizations and agencies subject to the law’s regulations are known as HIPAA-covered entities. However, whether HIPAA applies to medical data gathered by AI depends entirely on who is deploying the technology, according to the research team.

Those HIPAA entities include providers such as doctors and psychologists and their clinics or practices. Health plans — whether from health insurance companies, an employer or the government — are also covered. Essentially, HIPAA applies to any individual or entity that comes into contact with or processes protected health information.

Importantly, however, medical information handed over to chatbots used by companies outside the health care industry do not appear to receive the same protections.

De-identifying Data

Regardless of where it’s collected, health data can be altered to remove HIPAA protections. It is common that protected health data is stripped of identifying information, such as a patient’s name, in a process known as de-identification. This de-identified health data can then be sold to anyone from data brokers to pharmaceutical companies. This a very lucrative industry, and has existed for decades. In the case of the pharmaceutical industry, prescription and insurance information can be purchased to in turn target doctors for marketing purposes.

Re-identifying Data

HIPAA and healthcare providers seem comfortable that the patient’s data is adequately protected and that this practice of selling anonymous data is acceptable. Recently, a team of researchers reported on the ease of re-identifying health care information, raising serious questions over HIPAA’s validity in the age of AI.

The New York University research team found re-identifying data to be trivial. The team believes that HIPAA’s protections “are rapidly becoming outdated,” and demonstrated how AI can be used to examine anonymized patient notes to determine an identity. “We believe HIPAA needs urgent updates to offer more robust protections against the sale of this data and we should exercise care when handling clinical notes,” said one of the researchers.

Source: Jiang LY, Liu XC, Cho K, Oermann EK. Paradox of De-identification:
A Critique of HIPAA Safe Harbour in the Age of LLMs.
 arXiv:2602.08997v1 [Computers and Society (cs.CY)]  9 Feb 2026. https://doi.org/10.48550/arXiv.2602.08997


Interview with Ronald C. Kessler: Elucidating The Population Burden of Mental Disorders 2026

Dr. Ronald C. Kessler, Professor of Health Care Policy at Harvard Medical School is most widely recognized as the world’s most published and influential psychiatric epidemiologist. He has been internationally known over the last few decdes for leading major national and global epidemiological surveys on the population prevalence and correlates of mental disorders. His work has transformed how the field understands the burden, distribution, and treatment of common mental illnesses and suicide-related behaviors. Dr. Kessler was the Principal Investigator of the US National Comorbidity Survey, the first nationally representative survey of mental disorders in the United States, and numerous follow-up and replication studies that have mapped changes in mental health and service use over time. He served as Director of the World Health Organization World Mental Health Survey Initiative, a program of community surveys in over 30 countries that has provided the empirical foundation for national mental health policies and resource allocation decisions worldwide.

In a new interview published today in Genomic Psychiatry by Genomic Press, Dr Kessler describes how population-scale surveys across more than 30 countries revealed staggering treatment gaps and what he is now doing to close them. Recognized as the most cited author in psychiatry and psychology worldwide, with more than 1,300 publications cited over 330,000 times, Dr. Kessler built the infrastructure for measuring mental illness at the population level, work that spans continents and has reshaped how governments allocate resources for psychiatric care.

He discusses his career path and choices and highlights things he might have done differently or at a different point in time. He also describes the things that have influenced him and what were his primary focal points within his chosen field of science. He discusses what he enjoys most in his life’s work and what he believes still needs to be accomplished in the field.

He also describes how he spends his “off-time” and what he does for fun and enjoyment.

A part 2 is a series of selected questions from the Proust Questionnaire.

Citation: Kessler, RC. Shining Light on the Hidden Impact of Mental Disorders on People and Communities Everywhere. Genomic Psychiatry. Publ.. Feb 3, 2026. DOI: 10.61373/gp026k.0021